Sexual Dysfunction Disorders
Introduction
Sexual dysfunction disorders are characterized by clinically significant disturbances in an individual’s ability to respond sexually or to experience sexual pleasure. According to the DSM-5-TR, these disorders involve impairments in desire, arousal, orgasm, or pain associated with sexual activity.
These disturbances must persist for a significant duration, cause distress, and not be better explained by another mental disorder, medical condition, or substance use. Carson and Butcher emphasize that sexual functioning is influenced by both psychological and biological factors, and dysfunctions often arise from their interaction.
Delayed Ejaculation
Diagnostic Features
Delayed Ejaculation is characterized by marked delay, infrequency, or absence of ejaculation despite adequate sexual stimulation. The individual may experience prolonged sexual activity without ejaculation, leading to distress or frustration.
DSM-5-TR Diagnostic Criteria
A. Marked delay in ejaculation, marked infrequency or absence of ejaculation on almost all or all occasions of partnered sexual activity.
B. The symptoms in Criterion A have persisted for a minimum duration of approximately 6 months.
C. The symptoms cause clinically significant distress in the individual.
D. The sexual dysfunction is not better explained by a nonsexual mental disorder or severe relationship distress and is not attributable to substances or another medical condition.
Etiology / Causes
Psychological causes include performance anxiety, stress, and restrictive attitudes toward sexuality.
Biological causes may include neurological issues, hormonal imbalance, or medication side effects.
Risk and Prognostic Factors
Risk factors include aging, chronic illness, and relationship difficulties.
Prognosis varies depending on underlying cause but improves with appropriate intervention.
Treatment
Treatment focuses on addressing both psychological and physiological contributors to ejaculation difficulties. Since sexual functioning is influenced by multiple interacting systems, interventions are typically comprehensive and individualized.
Psychotherapy may help reduce performance anxiety, address restrictive beliefs, and improve communication between partners. Behavioral techniques can help enhance arousal and responsiveness. In cases where medications or medical conditions contribute to the dysfunction, appropriate medical management is required. Education and reassurance also play an important role in reducing distress and improving sexual functioning.
Erectile Disorder
Diagnostic Features
Erectile Disorder involves difficulty in obtaining or maintaining an erection sufficient for satisfactory sexual performance. The difficulty occurs consistently and leads to distress.
DSM-5-TR Diagnostic Criteria
A. Marked difficulty in obtaining an erection during sexual activity, maintaining an erection until completion, or marked decrease in erectile rigidity.
B. The symptoms in Criterion A have persisted for at least 6 months.
C. The symptoms cause clinically significant distress.
D. The dysfunction is not better explained by another disorder or medical condition.
Etiology / Causes
Psychological causes include anxiety, depression, and performance pressure.
Biological causes include vascular disease, diabetes, hormonal imbalance, and neurological impairment.
Risk and Prognostic Factors
Risk factors include aging, cardiovascular disease, unhealthy lifestyle, and stress.
Prognosis is generally good when underlying causes are treated.
Treatment
Treatment focuses on restoring erectile functioning by addressing both biological and psychological factors. Because erection depends on vascular, neurological, and emotional systems, a multidisciplinary approach is often necessary.
Medical treatments such as phosphodiesterase inhibitors are commonly used and are highly effective in many cases. Psychological interventions help reduce performance anxiety and improve confidence. Lifestyle changes such as regular exercise, reduced substance use, and improved overall health also contribute significantly to recovery.
Female Orgasmic Disorder
Diagnostic Features
Female Orgasmic Disorder is characterized by delay, infrequency, or absence of orgasm despite adequate stimulation. The individual may experience reduced intensity of orgasm or difficulty reaching climax.
DSM-5-TR Diagnostic Criteria
A. Marked delay, infrequency, absence of orgasm, or markedly reduced intensity of orgasmic sensations on almost all or all occasions of sexual activity.
B. Symptoms have persisted for at least 6 months.
C. Causes clinically significant distress.
D. Not better explained by another condition.
Etiology / Causes
Psychological causes include anxiety, lack of sexual knowledge, and relationship issues.
Biological factors include hormonal influences and medical conditions.
Risk and Prognostic Factors
Risk factors include limited sexual education, stress, and interpersonal difficulties.
Prognosis is favorable with appropriate intervention.
Treatment
Treatment focuses on enhancing sexual awareness and reducing psychological barriers to orgasm. Because orgasm involves both physical stimulation and psychological readiness, interventions target both domains.
Therapy may include sexual education, communication training, and behavioral exercises to improve responsiveness. Addressing anxiety, improving comfort with sexual experiences, and strengthening intimacy between partners are key aspects of treatment.
Female Sexual Interest/Arousal Disorder
Diagnostic Features
This disorder involves reduced or absent sexual interest, arousal, and responsiveness. Individuals may report lack of desire, reduced excitement, and diminished physical or emotional arousal.
DSM-5-TR Diagnostic Criteria
A. Lack of, or significantly reduced, sexual interest/arousal, as manifested by at least three of the following:
- Absent or reduced interest in sexual activity
- Absent or reduced sexual thoughts or fantasies
- Reduced initiation of sexual activity
- Reduced excitement during sexual activity
- Reduced interest in sexual cues
- Reduced genital or non-genital sensations
B. Symptoms persist for at least 6 months.
C. Causes clinically significant distress.
D. Not better explained by other conditions.
Etiology / Causes
Psychological causes include stress, depression, trauma, and relationship conflict.
Biological causes include hormonal changes, especially during menopause.
Risk and Prognostic Factors
Risk factors include hormonal fluctuations, chronic stress, and dissatisfaction in relationships.
Prognosis improves with integrated treatment.
Treatment
Treatment focuses on enhancing both desire and arousal by addressing psychological and biological contributors. Since sexual response involves complex interactions, interventions are typically comprehensive.
Psychotherapy helps address emotional, cognitive, and relational factors affecting desire. Behavioral strategies may improve intimacy and responsiveness. Hormonal or medical treatments may be considered when physiological factors are involved. Education and open communication are essential components of treatment.
Genito-Pelvic Pain/Penetration Disorder
Diagnostic Features
This disorder involves persistent difficulties with vaginal penetration, pain during intercourse, and fear or anxiety related to sexual activity. Individuals may also exhibit involuntary muscle tightening.
DSM-5-TR Diagnostic Criteria
A. Persistent or recurrent difficulties with one or more of the following:
- Vaginal penetration during intercourse
- Marked pain during intercourse
- Fear or anxiety about pain
- Marked tensing of pelvic floor muscles
B. Symptoms persist for at least 6 months.
C. Causes clinically significant distress.
D. Not better explained by other conditions.
Etiology / Causes
Psychological causes include fear, anxiety, and trauma.
Biological causes include infections, injury, or medical conditions affecting the pelvic region.
Risk and Prognostic Factors
Risk factors include history of trauma, pain disorders, and anxiety.
Prognosis is generally good with appropriate treatment.
Treatment
Treatment focuses on reducing pain and anxiety associated with penetration. Because both physical and psychological factors are involved, a multidisciplinary approach is often required.
Behavioral techniques such as gradual desensitization and pelvic floor relaxation exercises are commonly used. Medical treatment may address underlying physical causes. Psychological therapy helps reduce fear, improve comfort, and enhance sexual functioning.
Male Hypoactive Sexual Desire Disorder
Diagnostic Features
This disorder involves persistently reduced or absent sexual thoughts and desire for sexual activity. Individuals show decreased motivation for sexual engagement.
DSM-5-TR Diagnostic Criteria
A. Persistently deficient sexual thoughts or desire.
B. Symptoms persist for at least 6 months.
C. Causes distress.
D. Not better explained by other conditions.
Etiology / Causes
Psychological causes include stress, depression, and relationship issues.
Biological causes include hormonal imbalance and chronic illness.
Risk and Prognostic Factors
Risk factors include aging, stress, and health conditions.
Prognosis improves with appropriate treatment.
Treatment
Treatment focuses on improving sexual desire by addressing both psychological and biological factors. Since desire is influenced by emotional, relational, and physiological processes, treatment is usually multifaceted.
Psychotherapy helps address underlying emotional issues, relationship problems, and negative beliefs about sexuality. Behavioral interventions aim to increase intimacy and responsiveness. Medical treatments such as hormone therapy may be considered when biological causes are identified.
Premature (Early) Ejaculation
Diagnostic Features
Premature ejaculation involves ejaculation that occurs earlier than desired, often within one minute of penetration, leading to distress and lack of control.
DSM-5-TR Diagnostic Criteria
A. Ejaculation occurring within approximately 1 minute following vaginal penetration and before the individual wishes it.
B. Present for at least 6 months and occurs in most sexual encounters.
C. Causes distress.
D. Not better explained by other conditions.
Etiology / Causes
Psychological causes include anxiety and conditioning.
Biological causes include heightened sensitivity.
Risk and Prognostic Factors
Risk factors include anxiety and early learning patterns.
Prognosis is generally favorable.
Treatment
Treatment focuses on improving control over ejaculation and reducing associated anxiety. Behavioral techniques are highly effective and form the core of intervention.
Methods such as the stop-start technique and squeeze technique help individuals gain better control. Psychological therapy addresses performance anxiety, while medications such as SSRIs may be used in some cases to delay ejaculation.
Substance/Medication-Induced Sexual Dysfunction
Diagnostic Features
This disorder involves sexual dysfunction directly caused by substance use, medication, or toxin exposure. Symptoms may include impaired desire, arousal, or orgasm.
DSM-5-TR Diagnostic Criteria
A. Prominent disturbance in sexual functioning.
B. Evidence that the dysfunction developed during or soon after substance use or medication exposure.
C. Not better explained by a non-substance-related disorder.
D. Causes clinically significant distress.
Etiology / Causes
Direct physiological effects of substances such as alcohol, drugs, or medications.
Risk and Prognostic Factors
Risk factors include long-term substance use and certain medications.
Prognosis is good if the substance is removed.
Treatment
Treatment focuses on identifying and eliminating the substance or medication responsible for the dysfunction. Since the symptoms are directly linked to physiological effects, addressing the underlying cause often leads to improvement.
Medical supervision may be required to adjust medications or manage withdrawal. Psychological support may also help individuals cope with distress and restore normal sexual functioning.
References
- American Psychiatric Association (2022). DSM-5-TR
- Carson & Butcher, Abnormal Psychology
Niwlikar, B. A. (2026, May 3). Sexual Dysfunction Disorders. Careershodh. https://www.careershodh.com/sexual-dysfunction-disorders/